Daily non-political popular news in brief.
Preventing lung scarring may extend lives of lung cancer patients
10-29-2007 · EurekAlert!Researchers have found that using a special type of drug called a pharmaceutical monoclonal antibody to block the integrin beta6-TGF-beta pathway prevents a serious side effect of radiation therapy for lung cancer patients -- pulmonary fibrosis -- thereby extending patients' lives and improving their quality of life, according to a study presented at the Plenary I session on Oct. 29, 2007, at the American Society for Therapeutic Radiology and Oncology's 49th Annual Meeting in Los Angeles.
Read more »
Keywords: preventing, lung, scarring, extend, lives, cancer, patients, live, patient
« Previous | Next »
Similar news on "Preventing lung scarring may extend lives of lung cancer patients":
- Jefferson researchers show chemotherapy and radiation together extend lung cancer patients' lives
11-09-2007 · EurekAlert!
Chemotherapy given at the same time as radiation therapy can help patients with a certain type of lung cancer live nearly 50 percent longer than they might have otherwise if the same treatment was given differently, according to an international team’s analysis of several trial results.
Similar news · Read more »
- Pre-treatment blood test could guide lung cancer therapy
06-05-2007 · EurekAlert!
A multi-center team, led by Vanderbilt-Ingram Cancer Center investigators, has developed a new pre-treatment blood test that predicts which non-small-cell lung cancer patients will live longer when they are treated with certain targeted cancer therapies (Iressa, Tarceva). The mass spectrometry-based test, described in the June 6 Journal of the National Cancer Institute, may allow physicians to select the most beneficial therapy for each lung cancer patient, a step forward in the era of personalized medicine.
Similar news · Read more »
- Gleevec, the targeted cancer pill, delivers more good news to patients
12-09-2007 · EurekAlert!
Gleevec, the targeted cancer pill that has saved more than 100,000 lives, now is saving more children with a dire leukemia, as well as preventing disease progression with long term use in adults with chronic myeloid leukemia.
Similar news · Read more »
- Radiation after surgery doubles survival time for some lung cancer patients
11-06-2006 · EurekAlert!
Patients with lung cancer that has spread to mediastinal lymph nodes -- located between the chest, breastbone and spine -- who receive radiation after surgery and chemotherapy live twice as long as patients who do not receive radiation after surgery, according to a study presented at the plenary session November 6, 2006, at the American Society for Therapeutic Radiology and Oncology's 48th Annual Meeting in Philadelphia.
Similar news · Read more »
- New treatment finds success treating tiniest lung tumors
11-08-2006 · EurekAlert!
Patients with metastatic cancer tumors in their lungs are much more likely to live disease-free if they have an experimental treatment involving shaped-beam radiosurgery rather that conventional treatment, according to a University of Rochester Medical Center study.
Similar news · Read more »
- Family counseling improves lives of patients and spouses coping with prostate cancer
11-12-2007 · EurekAlert!
Families coping with prostate cancer report improved quality of life from a structured support program integrated into the patient's cancer management, according to a new study.
Similar news · Read more »
- Support groups don't extend survival of metastatic breast cancer patients, Stanford study finds
07-23-2007 · EurekAlert!
A new study from a team of Stanford University School of Medicine researchers led by David Spiegel, MD, shows that participating in support groups doesn't extend the lives of women with metastatic breast cancer. The results differ from oft-cited previous findings by Spiegel, that showed group psychotherapy extended survival time.
Similar news · Read more »
- From clinical cancer research: rethinking therapeutic cancer vaccine trials
07-03-2007 · EurekAlert!
Ongoing therapeutic cancer vaccine trials have yet to show evidence of vaccines spurring a patient's immune system to shrink tumors -- yet patients who receive these vaccines in trials tend to live longer and respond better to subsequent treatment. In the July 1 issue of Clinical Cancer Research, a journal of the American Association for Cancer Research, a team of National Cancer Institute researchers asks a fundamental question: are we looking at cancer vaccine trials the wrong way?
Similar news · Read more »
- Quality of life: most important predictor of survival for advanced NSCLC patients
10-30-2007 · EurekAlert!
Healthcare providers have observed it for years -- patients who appear to have a better quality of life while battling their cancer live longer. Now, a prospective, multi-institutional study examining the quality of life of patients with locally advanced non-small cell lung backs that observation. In fact, quality of life is so important, it outweighs other classic predictors of survival.
Similar news · Read more »
- Spending more for lung cancer treatment did not substantially increase patients' lives
10-22-2007 · EurekAlert!
A new study finds that survival for elderly patients with lung cancer has changed little despite large increases in healthcare expenditures for lung cancer treatment.
Similar news · Read more »
